Immunotherapy with radiation — does one help the other?

In defined situations, yes, and it is done routinely. Radiation therapy and checkpoint inhibitor immunotherapy are combined in guideline-backed plans, and short courses of radiation are often given while immunotherapy continues. The combination is not without risk. Its one important shared risk is inflammation of the lungs.

The reason that rule comes first is simple. Radiation to the chest can inflame lung tissue, and checkpoint inhibitor immunotherapy can inflame lung tissue. When both are in your plan, a new breathing symptom has two possible causes and both need assessing quickly. Everything else on this page is less urgent than that.

Beyond the lungs, the picture is more reassuring than most people expect. Skin inside the radiation field can react more strongly than radiation alone would explain. Tiredness usually builds through a course of radiation. Most other immune side effects, such as thyroid or gut inflammation, are not made worse by radiation itself. NCCN, ASCO and ESMO patient-education material sets out this same risk profile.

Whether the combination applies to you is a decision for your treating team. Cancer type and stage, the site being irradiated, your lung function, other illnesses and how well you are day to day all feed into it. Nothing on this page can make that call, and it is not meant to.

The abscopal effect is when radiation given to one tumour is followed by shrinkage of a different, untreated tumour elsewhere in the body. The proposed reason is that radiation breaks open cancer cells and releases fragments the immune system can recognise. It is real, and it is rare.

The word comes from Latin and Greek roots meaning “away from the target”. That is exactly what makes it striking. A treatment aimed at one place appears to act somewhere it never reached.

Here is the honest state of the evidence, because this is where most pages on this topic get carried away. Most of what is known comes from individual case reports rather than large trials. Studies that deliberately added radiation to immunotherapy in the hope of triggering it have not reproduced it reliably. Guideline bodies describe it as an area of active research, not as an established reason to add radiation.

So it is worth understanding, and it is worth asking your oncologist about. It is not worth requesting radiation for. If radiation is added to your plan, expect the stated reason to be a local one — controlling a site, relieving a symptom, treating disease where it is — and treat any immune benefit as a possibility rather than a plan.

You can read the mechanism in more depth on the radiation side of the site: The Abscopal Effect: Can Radiating One Tumour Shrink Another?

Radiation is delivered at CION radiation centres and immunotherapy is given as day care. Response-assessment imaging is coordinated at partner imaging centres. Ask your team which of the four situations above your plan is, and why that one.

Yes, and the order is set by your treating team before either treatment starts. There are three broad patterns, plus the option of not combining at all. Which one applies depends on your cancer, the site being treated and how well you are — not on preference, and not on which sounds strongest.

1. 1

   Radiation first, immunotherapy afterwards

   The most established pattern. A course of radiation, usually with chemotherapy, is completed first, and immunotherapy begins once that is finished and you have recovered enough. The gap between the two is planned, not accidental.

2. 2

   Immunotherapy running, radiation added part-way

   The commonest in day-to-day practice. One site needs treating while the rest is controlled. A short radiation course is fitted around the immunotherapy cycles, and the immunotherapy usually continues.

3. 3

   Both at the same time

   Used more selectively. The decision turns on which part of the body is being irradiated and how much normal lung, heart or brain tissue is in the field. It is not automatically stronger than the other two.

4. 4

   One or the other, not both

   For many cancers, guideline-backed treatment is radiation alone or immunotherapy alone. Adding the second is not an upgrade, and being offered a single treatment does not mean anything is being withheld.

Honest caveat: for most situations outside locally advanced lung cancer, the evidence on the ideal gap and the ideal order is still developing. Where the answer is not settled, your tumour board makes a judgement based on your case. If the plan changes part-way, ask what changed and why. Every reasonable team will explain it in plain language.

The same question comes up around the other treatments in a plan. We cover the surgery version on Immunotherapy After Surgery vs Before: Which Order? and the chemotherapy gap on How Long After Chemotherapy Can Immunotherapy Start?

Often it cannot be told apart from symptoms alone. Both cause a dry cough, breathlessness and sometimes a low fever. The scan pattern helps, because radiation-related inflammation usually follows the shape of the treated area while immune-related inflammation is more scattered. Timing helps too, though the windows overlap.

In practice your team may begin treating for the more dangerous possibility while the picture becomes clearer, rather than waiting for certainty. That is the correct order of operations, and it is another reason the same-day rule exists. Call your oncology team or the CION helpline on 1800 202 8726, or go to the emergency department if you cannot reach anyone.

The radiation-side detail on this symptom, including what the assessment involves, is on Radiation Pneumonitis: Cough and Breathlessness After Chest Radiation.

This page is written from the immunotherapy side. The radiation cluster covers the same combination from the other direction, and the pages below are the ones worth reading next depending on which decision you are actually facing.

• Radiation With Immunotherapy: Is the Combination Safe? — the mirror of this page, written for someone whose starting point is a radiation plan rather than an immunotherapy one.
• Immunotherapy With Targeted Therapy: When They Are Combined — the other combination question that comes up most often, and the situations where the two are deliberately kept apart.
• Immunotherapy After Surgery vs Before: Which Order? — the same sequencing logic applied to surgery, where the before-or-after decision is made earlier in the journey.
• How Long After Chemotherapy Can Immunotherapy Start? — what actually determines the gap between treatments, and why a wait is usually planned rather than a delay.
• Radiation Therapy at CION Cancer Clinics — how radiation is planned and delivered at our centres, including what a short palliative course involves.

Most of the fear around combining these two treatments comes from not knowing which decisions have already been made, and why. These five questions get you that in one conversation.

• Which of the four situations is my plan — radiation first, radiation added part-way, both together, or one alone?
• What is the radiation actually for: controlling a site, relieving a symptom, or part of a defined pathway?
• Do my immunotherapy cycles pause during the radiation course, or continue on schedule?
• How much lung is in the treated area, and what breathing symptoms should I report the same day?
• What is the estimated cost of the full plan, and what will insurance or a government scheme cover?

A 45-minute consultation at CION is designed to leave you with those answers in writing rather than in memory, with the plan reviewed by a tumour board rather than one doctor. You can read how the service is delivered on Immunotherapy at CION Cancer Clinics — including how treatment is given as day care and how response scans are coordinated with our partner imaging centres. Any cost figure quoted is indicative, as of August 2026, and is confirmed in writing before treatment starts.

This page is general information and does not replace a consultation. It describes treatment classes only, not specific medicines or regimens, and it recommends no treatment. The safety and sequencing patterns here are drawn from NCCN, ASCO and ESMO patient-education guidance; they are general, and no outcome figure of any kind is implied. Every decision about whether to combine radiation with immunotherapy, and in what order, belongs with your own treating team.

Get a second opinion on your combination plan

Free, written, and reviewed by our tumour board — so you know why radiation is in your plan, and in what order.